ANO1 and gastrointestinal stromal tumor: Recent evidence suggests that ANO1 is a potential therapeutic target for various cancers, including gastrointestinal stromal cancer (GIST), head and neck squamous cell carcinoma (HNSCC), and oral squamous cell carcinoma (OSCC) [10,11,33].